智通财经APP获悉，微创医疗(00853)涨超5%，截至发稿，涨5.19%，报1.42港元，成交额1946.91万港元。
消息面上，近日，微创医疗公布心脉医疗2025年年度业绩快报，营业总收入约13.51亿元，同比增长11.96%；归属于母公司所有者的净利润约5.63亿元，同比增长12.17%；基本每股收益4.65元。报告期内，公司海外销售收入超过2.5亿元，同比增长超过 55%，在公司收入占比提升至18%以上，并且公司持续推动全球范围内与区域行业领先客户的合作，持续推进主动脉及外周介入产品在欧洲、拉美、亚太等国家的市场准入和推广工作。
公司在研产品稳步推进，管线丰富，其中Aegis II腹主动脉覆膜支架系统完成注册资料递交；Hector胸主多分支覆膜支架系统已进入国内上市前多中心临床阶段，且于报告期内进入国家创新“绿色通道”，并已通过欧盟定制方式实现商业化，同时该产品美国Breakthrough Device Designation申请已提交FDA；胸腹主动脉覆膜支架系统(定制)已获得国内备案证；髂动脉分支覆膜支架系统即将进入临床试验启动阶段。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.